Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 12, 2017 FBO #5619
SOLICITATION NOTICE

65 -- HIGH RESOLUTION AND SEQUENCE BASED REAGENTS FOR TRANSFUSION MEDICINE

Notice Date
4/10/2017
 
Notice Type
Presolicitation
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
 
ZIP Code
20892-5480
 
Solicitation Number
17-006030
 
Archive Date
5/10/2017
 
Point of Contact
Malinda Dehner, Phone: 301-594-6320, Barbara Taylor, Phone: 301-594-5915
 
E-Mail Address
dehnerm@cc.nih.gov, Barbara_Taylor@nih.gov
(dehnerm@cc.nih.gov, Barbara_Taylor@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health, Clinical Center (CC) intends to award a fixed price purchase order to Qiagen, Valencia CA 91355-1005 on a sole source basis to procure specialized reagents and testing kits for use on the existing government-owned Qiagen GenoM-6 BioRobot EZ1® and the EZ1® Advanced XL isolation instruments used for automated nucleic acid extraction. This requirement is to provide reagents and testing kits to the Human Leukocyte Antigen, HLA lab, Services Section, that has been quality controlled for use on this specific instrumentation. The quality control process is an American Society for Histocompatibility and Immunogenetics (ASHI) and Clinical Lab for Improvements Amendment (CLIA) regulation as the consumables for patient care must be found suitable and in accordance with the manufacturer's instructions. The Qiagen EZ1 reagents and kits are necessary to perform high resolution and sequence based testing for transplant patients and donors who must both be matched for peripheral blood stem cell and cord blood transplants. No transplants can occur unless these high resolution results are received and approved by a CC physician. Qiagen is the sole manufacturer and distributor of the EZ1 Kit chemistry. The comprehensive system of instruments and consumables is necessary to produce a complete testing result. The below supply and quantity is required for a twelve (12) month time period from award: Item# Description Quantity 951054 EZ1 DNA Blood 350 ul kit (48) 84 This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(i), Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Each response should include the following Business Information: a. DUNS. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Type of Company (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1 e. Capability Statement Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Malinda Dehner, Contract Specialist, dehnerm@cc.nih.gov by the due date and time marked in this notice.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/17-006030/listing.html)
 
Place of Performance
Address: 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN04465644-W 20170412/170410235051-d6e199684804d0b3b909525b36b7ed1f (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.